Definitive Contract 75N95025C00008

Award Date 9/1/25
Potential Completion Date 8/31/27
Potential Value $2M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Robbinsville Twp, NJ, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute on Drug Abuse awarded a Small Business Innovation Research (SBIR) Phase I contract to Portable Diagnostic Systems Inc. in Robbinsville, New Jersey. The contract, with a potential value of $400,000.00, is for the development of an ultraportable lab-on-a-chip biosensor system for rapid postmortem toxicology. The period of performance is September 27, 2023 to September 26, 2024, and the...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $24,900 firm fixed price purchase order contract to Pelago Bioscience AB, a for-profit limited liability company. The contract is for the development of a new assay to test compounds of interest. The period of performance runs from the award date of September 9, 2024 through September 8, 2025. This contract award does not have a set-aside designation.</p>
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse to Advanced Silicon Group, Inc., a woman-owned small business. The contract, valued at $400,000.00, is for research and development of a biosensor prototype that can detect drugs in postmortem blood samples using coupled acoustical wave micropillar technology. The contract is a firm fixed-price definitive contract with a completion date of...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $2,451,736.00 cost-plus-fixed-fee contract to Medispin Inc., a small business, for R&amp;D in physical science. The 3-year contract (ultimate completion date of Nov 30, 2009) was awarded on Sep 22, 2006 under a total small business set-aside. The contract is for research and experimental development activities related to the agency's mission.</p>
<p>The National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $24,999.10 firm fixed-price purchase order to Vizioli Omics to complete research and analysis leading to the submission of manuscripts for publication. The contract, which does not have a set-aside designation, has a period of performance through June 24, 2025. This award appears to be for a standalone project and is not associated with a larger contract vehicle.</p>
This is a $300,000.00 Firm Fixed Price Definitive Contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Base Pair Biotechnologies Inc., a small business concern, to develop aptasensors for measuring long-term adherence to tenofovir-based and long-acting HIV treatment regimens. The contract was awarded under the Small Business Innovation Research (SBIR) program, which is designed to stimulate technological...
S-3 Research LLC has been awarded a $1.5 million firm fixed price contract by the National Institutes of Health's National Institute on Drug Abuse to further develop and commercialize a minimum viable product originally created under Phase I of the Small Business Innovation Research program. Over the next two years, the company will focus on four technical objectives to expand its product offering and successfully bring the Phase I technology to market. The award is designated for total small...
<p>The National Institute on Drug Abuse (NIDA), a civilian federal agency, awarded a $12,000.00 firm-fixed-price purchase order contract to Vivpro Corp, a self-certified small disadvantaged business, for subscription licenses. The contract has an ultimate completion date of June 24, 2025 and was awarded on June 13, 2024. This contract does not have a set-aside designation.</p>
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $430,700.00 firm fixed price contract to High Throughput Biology Inc., a minority-owned, small disadvantaged business, for the development of an array-based multiplex immunoassay for postmortem toxicology screening under the Small Business Innovation Research (SBIR) program. The contract, which is set aside for small businesses, has a completion date of September 24, 2024. High...
This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency under the Department of Health and Human Services (HHS), to Stripes Global, Inc., a Service-Disabled Veteran-Owned Small Business (SDVOSB), HUBZone, and Small Disadvantaged Business. The $83,400.00 fixed-price award is for the purchase of a Sapphire Biomolecular Imager Scanning System to support NIDA's Intramural Research Program's molecular and cellular research on drug abuse and addiction....

The U.S. National Institute on Drug Abuse (NIDA), a civilian federal agency, has awarded a $2,000,000.00 Firm Fixed Price Definitive Contract to Portable Diagnostic Systems Inc., a Veteran Owned Business, for the development of an Ultraportable Lab-on-a-Chip Biosensor System for Rapid Postmortem Toxicology under the Small Business Innovation Research (SBIR) program. The period of performance is from September 1, 2025 to August 31, 2027. This SBIR Phase II contract is a set-aside for small businesses.

Generated 8/27/25, 9:47 AM